Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-004051-35-DE
EUCTR2005-004051-35-DE
Active, not recruiting
Not Applicable

Intramyocardial Application of Stem Cells in combination with transmyocardial Laser Revascularisation (TMLR) in CABG Patients - INSTEM-Trial

niversity Hospital Düsseldorf0 sitesJanuary 20, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOther forms of chronic ischaemic heart diseaseMedDRA version: 70Level: LLTClassification code 10032058

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Other forms of chronic ischaemic heart disease
Sponsor
niversity Hospital Düsseldorf
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity Hospital Düsseldorf

Eligibility Criteria

Inclusion Criteria

  • •\- over 18 years
  • •\- presence of at least two vessel coronary artery disease with at least one vessel
  • •that is not amenable to CABG surgery and serves an area of viable myocardium
  • •\- signed informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- any condition that prevents succesful stem cell collection
  • •\- predominant existence of nonviable myocardium
  • •\- no informed consent
  • •\-pervious heart surgery within the last six months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
INtramyocardial application of STEM cells in combination with transmyocardial laser revascularisation in coronary artery bypass graft patientsCoronary artery bypass graftCirculatory System
ISRCTN49998633Heinrich-Heine-University (Germany)40
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-DEDepartment of Cardiology, Rigshospitalet139
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-DKDepartment of Cardiology, Rigshospitalet138
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000011680Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-PLDepartment of Cardiology, Rigshospitalet139
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 18.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-NLDepartment of Cardiology, Rigshospitalet139